Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chiron pharma research

Executive Summary

Pharmacia VP-Discovery Oncology Kenneth Bair, MD, joins Chiron as senior VP-BioPharma research head, effective July 1. He will oversee chemistry, biology, applied biochemistry and discovery projects, and "work with the research head of Chiron's Vaccines and Blood Testing business units to promote organizational synergies," Chiron says. Chiron acquired the vaccine manufacturer Powderject in May (1"The Pink Sheet" May 26, 2003, p. 17). Invenux CEO Carl Pelzel joins Chiron as VP-BioPharma commercial operations...
Advertisement

Related Content

Chiron Vaccines Get Shot In The Arm With PowderJect Needleless Technology
Chiron Vaccines Get Shot In The Arm With PowderJect Needleless Technology
Advertisement
UsernamePublicRestriction

Register

PS042035

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel